1. What is Atorvastatina Vir Pharma and what it is used for
2. What you need to know before starting to take Atorvastatina Vir Pharma
3. How to take Atorvastatina Vir Pharma
4. Possible adverse effects
5. Storage of Atorvastatina Vir Pharma
6. Contents of the pack and additional information
Atorvastatina belongs to a group of medicines known as statins, which are medicines that regulate lipids (fats).
Atorvastatina is used to reduce lipids such as cholesterol and triglycerides in the blood when a low-fat diet and lifestyle changes on their own have failed. If you have a high risk of heart disease, atorvastatina may also be used to reduce this risk even if your cholesterol levels are normal. During treatment, a standard low-cholesterol diet must be followed.
Do not take Atorvastatina Vir Pharma
Warnings and precautions
Consult your doctor, pharmacist, or nurse before starting to take Atorvastatina Vir Pharma:
In any of these cases, your doctor may instruct you to have blood tests before and possibly during treatment with Atorvastatina Vir Pharma to predict the risk of adverse effects related to muscle. It is known that the risk of adverse effects related to muscle (e.g., rhabdomyolysis) increases when certain medications are taken at the same time (see Section 2 “Use of Atorvastatina Vir Pharma with other medications”).
Also inform your doctor or pharmacist if you experience persistent muscle weakness. Additional tests and medications may be necessary to diagnose and treat this problem.
While you are taking this medication, your doctor will monitor if you have diabetes or are at risk of developing diabetes. This risk of diabetes increases if you have high blood sugar and fat levels, obesity, and high blood pressure.
Use of Atorvastatina Vir Pharma with other medications
Inform your doctor or pharmacist if you are taking, have taken recently, or may need to take any other medication. There are some medications that may affect the proper functioning of Atorvastatina Vir Pharma or the effects of these medications may be modified by Atorvastatina Vir Pharma. This type of interaction may reduce the effect of one or both medications. Alternatively, this combined use may increase the risk or severity of adverse effects, including the important muscle deterioration, known as rhabdomyolysis described in Section 4:
Inform your doctor or pharmacist if you are using or may need to use any other medication.
Taking Atorvastatina Vir Pharma with food, drinks, and alcohol
See Section 3 for instructions on how to take Atorvastatina Vir Pharma. Please note the following:
Orange juice
Do not take more than one or two small glasses of orange juice per day, as large amounts of orange juice may alter the effects of Atorvastatina Vir Pharma.
Alcohol
Avoid drinking large amounts of alcohol while taking this medication. See details in Section 2 “Warnings and precautions”
Pregnancy, breastfeeding, and fertility
Do not take Atorvastatina Vir Pharma if you are pregnant, think you may be pregnant, or are trying to become pregnant.
Do not take Atorvastatina Vir Pharma if you are fertile and do not use adequate contraceptive measures.
Do not take Atorvastatina Vir Pharma if you are breastfeeding your child.
The safety of Atorvastatina Vir Pharma during pregnancy and breastfeeding has not been demonstrated.
Consult your doctor or pharmacist before using any medication.
Driving and operating machinery
Normally, this medication does not affect your ability to drive or operate machinery. However, do not drive if this medication affects your ability to drive. Do not operate tools or machinery if this medication affects your ability to handle them.
Atorvastatina Vir Pharma contains sodium
This medication contains less than 23 mg of sodium (1 mmol) per tablet; it is essentially “sodium-free”.
Before starting treatment, your doctor will put you on a low-cholesterol diet, which you should also follow during atorvastatina treatment.
The usual initial dose of atorvastatina is 10 mg once a day in adults and children aged 10 years and older. Your doctor may increase it if necessary to reach the dose you need. Your doctor will adjust the dose at intervals of 4 weeks or more. The maximum dose of atorvastatina is 80 mg once a day.
Atorvastatina tablets should be swallowed whole with a glass of water and can be taken at any time of the day with or without food. However, try to take your tablet every day at the same time.
Follow exactly the administration instructions for this medication indicated by your doctor or pharmacist. If in doubt, consult your doctor or pharmacist again.
Your doctor will decide the duration of treatment with atorvastatina.
Ask your doctor if you think the effect of atorvastatina is too strong or too weak.
If you take more Atorvastatina Vir Pharma than you should
In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone 91 562 04 20, indicating the medication and the amount ingested. Bring the remaining tablets, the packaging, and the complete box so that hospital staff can easily identify the medication taken.
If you forgot to take Atorvastatina Vir Pharma
If you forgot to take a dose, take the next scheduled dose at the correct time. Do not take a double dose to compensate for the missed doses.
If you interrupt treatment with Atorvastatina Vir Pharma
If you have any other questions about the use of this medication or want to interrupt treatment, ask your doctor or pharmacist.
Like all medicines, this medicine can cause side effects, although not everyone will experience them.
If you notice any of the following side effects or severe symptoms, stop taking these tablets and inform your doctor immediately or visit the nearest hospital emergency service.
Rare: may affect up to 1 in 1,000 people:
Very rare: may affect up to 1 in 10,000 people:
Other possible side effects of AtorvastatinVir Pharma:
Frequent may affect up to 1 in 10 people:
Infrequent: may affect up to 1 in 100 people:
Rare: may affect up to 1 in 1,000 people:
Very rare may affect up to 1 in 10,000 people:
Frequency unknown:cannot be estimated from available data
Possible side effects of some statins (medicines of the same type):
Reporting side effects
If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect that does not appear in this leaflet. You can also report them directly through the Spanish System for the Pharmacovigilance of Medicines for Human Use:https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medicine.
Keep this medication out of the sight and reach of children.
Store below30°C.
Do not use this medication after the expiration date that appears on the blister pack and on the packaging after CAD. The expiration date is the last day of the month indicated.
Medicines should not be disposed of through drains or in the trash. Dispose of the packaging and medicines you no longer need at the SIGRE collection pointat the pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. By doing so, you will help protect the environment.
Composition of Atorvastatina Vir Pharma
- The active ingredient is atorvastatina.
Cada comprimido recubierto con película contains 10 mg of atorvastatina (as atorvastatina cálcica).
The other components (excipients) are: microcrystalline cellulose, anhydrous sodium carbonate, maltose, sodium croscarmellose, magnesium stearate.
The coating of Atorvastatina Vir Pharma contains hypromelosa, hydroxypropylcellulose, triethylcitrate, polysorbate 80, titanium dioxide (E-171).
Appearance of the product and content of the container
The film-coated tablets of Atorvastatina Vir Pharma 10 mg are elliptical, concave, and white.
Atorvastatina Vir Pharma 10 mg is presented in boxes with blisters containing 28 film-coated tablets and in clinical containers containing 500 film-coated tablets.
Only some sizes of containers may be commercially marketed.
Holder of the marketing authorization and responsible for manufacturing
Holder of the marketing authorization:
INDUSTRIA QUÍMICA Y FARMACÉUTICA VIR, S.A.
C/Laguna 66-70. Polígono Industrial Urtinsa II
28923 Alcorcón (Madrid)
Spain
Responsible for manufacturing:
TEVA PHARMA, S.L.U.
C/ C nº 4 Polígono Industrial Malpica
50016 Zaragoza
Spain
Last review date of this leaflet:October 2024
The detailed information of this medicine is available on the webpage of the Spanish Agency of Medicaments and Health Products (AEMPS)http://www.aemps.gob.es/
Маєте питання щодо цього лікування або ваших симптомів? Зв'яжіться з ліцензованим лікарем для отримання допомоги та персонального догляду.